Am J Cardiol, 2020, 132, 150-157, 32819683 3 Barochiner J, Martínez R. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: a systematic review and meta-analysis. Gastroenterology, 2020, 159, 1170-1172, 32422208 19 Trifirò G, Massari M, Da Cas R, et al, ITA-COVID-19: RAAS Inhibitor Group., Renin-angiotensin-aldosterone system inhibitors and risk of death in patients hospitalised with COVID-19: a retrospective Italian cohort study of 43,000 patients. J Infect, 2020, 32800800 21 Baral R, White M, Vassiliou VS. Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients. [Extracted from the article]